Phage endolysins as new therapeutic options for multidrug resistant Staphylococcus aureus : an emerging antibiotic-free way to combat drug resistant infections.

Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.